The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
Open accessAbstract
An international expert panel was convened to deliberate the management of azole-resistant aspergillosis. In culture-positive cases, in vitro susceptibility testing should always be performed if antifungal therapy is intended. Different patterns of resistance are seen, with multi-azole and pan-azole resistance more common than resistance to a single triazole. In confirmed invasive pulmonary aspergillosis due to an azole-resistant Aspergillus, the experts recommended a switch from voriconazole to liposomal amphotericin B (L-AmB; Ambisome(®)). In regions with environmental resistance rates of ≥10%, a voriconazole-echinocandin combination or L-AmB were favoured as initial therapy. All experts recommended L-AmB as core therapy for central nervous system aspergillosis suspected to be due to an azole-resistant Aspergillus, and considered the addition of a second agent with the majority favouring flucytosine. Intravenous therapy with either micafungin or L-AmB given as either intermittent or continuous therapy was recommended for chronic pulmonary aspergillosis due to a pan-azole-resistant Aspergillus. Local and national surveillance with identification of clinical and environmental resistance patterns, rapid diagnostics, better quality clinical outcome data, and a greater understanding of the factors driving or minimising environmental resistance are areas where research is urgently needed, as well as the development of new oral agents outside the azole drug class.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Self-citationVoriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citationDenning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Self-citationTHE SPECTRUM OF THE DISEASE IN 98 PATIENTS
YOUNG, R. C., BENNETT, J. E., VOGEL, C. L., CARBONE, P. P., & DEVITA, V. T. (1970) · Medicine · doi:10.1097/00005792-197003000-00002 · Cited by 972
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
Denning, D. W., & Stevens, D. A. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.6.1147 · Cited by 899
Self-citationNeofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Self-citationEmergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Snelders, E., van der Lee, H. A. L., Kuijpers, J., Rijs, A. J. M. M., Varga, J., Samson, R. A., Mellado, E., Donders, A. R. T., Melchers, W. J. G., & Verweij, P. E. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050219 · Cited by 727
Self-citationMaertens, J., Raad, I., Petrikkos, G., Boogaerts, M., Selleslag, D., Petersen, F. B., Sable, C. A., Kartsonis, N. A., Ngai, A., Taylor, A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/423381 · Cited by 658
Self-citationAzole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Verweij, P. E., Snelders, E., Kema, G. H., Mellado, E., & Melchers, W. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70265-8 · Cited by 604
Self-citationCombination Antifungal Therapy for Invasive Aspergillosis: A Randomized Trial
Marr, K. A., Schlamm, H. T., Herbrecht, R., Rottinghaus, S. T., Bow, E. J., Cornely, O. A., Heinz, W. J., Jagannatha, S., Koh, L. P., Kontoyiannis, D. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m13-2508 · Cited by 514
Self-citationUpton, A., Kirby, K. A., Carpenter, P., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 514
Denning, D. W., Pleuvry, A., & Cole, D. C. (2013) · Medical Mycology · doi:10.3109/13693786.2012.738312 · Cited by 495
Self-citationHow to bolster the antifungal pipeline
Denning, D. W., & Bromley, M. J. (2015) · Science · doi:10.1126/science.aaa6097 · Cited by 481
Self-citationMaertens, J., Marchetti, O., Herbrecht, R., Cornely, O. A., Flückiger, U., Frêre, P., Gachot, B., Heinz, W. J., Lass-Flörl, C., Ribaud, P., et al. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.175 · Cited by 470
Self-citationClinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009
van der Linden, J. W. M., Snelders, E., Kampinga, G. A., Rijnders, B. J. A., Mattsson, E., Debets-Ossenkopp, Y. J., Kuijper, E. J., Van Tiel, F. H., Melchers, W. J. G., & Verweij, P. E. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110226 · Cited by 446
Self-citationTriazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus
Snelders, E., Camps, S. M. T., Karawajczyk, A., Schaftenaar, G., Kema, G. H. J., van der Lee, H. A., Klaassen, C. H., Melchers, W. J. G., & Verweij, P. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031801 · Cited by 427
Self-citationTissue Penetration of Antifungal Agents
Felton, T., Troke, P. F., & Hope, W. W. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-13 · Cited by 426
Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010
Bitar, D., Lortholary, O., Le Strat, Y., Nicolau, J., Coignard, B., Tattevin, P., Che, D., & Dromer, F. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.140087 · Cited by 426
Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
Snelders, E., Huis in 't Veld, R. A. G., Rijs, A. J. M. M., Kema, G. H. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00231-09 · Cited by 423
Self-citationGlobal burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis
Denning, D., Pleuvry, A., & Cole, D. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.089441 · Cited by 420 · cited 18×
“Patients with CPA, aspergillus bronchitis, ABPA, and severe asthma with fungal sensitisation (SAFS) often respond to antifungal therapy.”
BackgroundInfluentialImproved outcome in central nervous system aspergillosis, using voriconazole treatment
Schwartz, S. (2005) · Blood · doi:10.1182/blood-2005-02-0733 · Cited by 391
Chowdhary, A., Kathuria, S., Xu, J., & Meis, J. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003633 · Cited by 380
Self-citationGroll, A. H., Giri, N., Petraitis, V., Petraitiene, R., Candelario, M., Bacher, J. S., Piscitelli, S. C., & Walsh, T. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315643 · Cited by 373
Self-citationProspective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus
van der Linden, J. W. M., Arendrup, M. C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., Chryssanthou, E., Mellado, E., Kidd, S. E., Tortorano, A. M., et al. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2106.140717 · Cited by 371
Self-citation(2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02086.x · Cited by 370
van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit320 · Cited by 342
Self-citationFactors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
Nivoix, Y., Velten, M., Letscher‐Bru, V., Moghaddam, A., Natarajan‐Amé, S., Fohrer, C., Lioure, B., Bilger, K., Lutun, P., Marcellin, L., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/592255 · Cited by 342
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
Lortholary, O., Gangneux, J.-P., Sitbon, K., Lebeau, B., de Monbrison, F., Le Strat, Y., Coignard, B., Dromer, F., & Bretagne, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03548.x · Cited by 331
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
Pagano, L., Caira, M., Candoni, A., Offidani, M., Martino, B., Specchia, G., Pastore, D., Stanzani, M., Cattaneo, C., Fanci, R., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.012054 · Cited by 316
Denning, D. W., Park, S., Lass-Florl, C., Fraczek, M. G., Kirwan, M., Gore, R., Smith, J., Bueid, A., Moore, C. B., Bowyer, P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir179 · Cited by 313
Self-citationFactors associated with mortality in transplant patients with invasive aspergillosis
Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A., Anaissie, E. J., Walsh, T. J., Schuster, M. G., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/652768 · Cited by 303
Self-citationLockhart, S. R., Frade, J. P., Etienne, K. A., Pfaller, M. A., Diekema, D. J., & Balajee, S. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-11 · Cited by 231
Advances and challenges in management of invasive mycoses
Patterson, T. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67381-3 · Cited by 230
Camps, S. M. T., van der Linden, J. W. M., Li, Y., Kuijper, E. J., van Dissel, J. T., Verweij, P. E., & Melchers, W. J. G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05088-11 · Cited by 230
Self-citationAzole resistance in Aspergillus fumigatus: a growing public health concern
Vermeulen, E., Lagrou, K., & Verweij, P. E. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000005 · Cited by 204
Self-citationSchelenz, S., Barnes, R. A., Barton, R. C., Cleverley, J. R., Lucas, S. B., Kibbler, C. C., & Denning, D. W. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70006-x · Cited by 190
Self-citationChowdhary, A., Kathuria, S., Randhawa, H. S., Gaur, S. N., Klaassen, C. H., & Meis, J. F. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr443 · Cited by 188
Self-citationEmergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany
Steinmann, J., Hamprecht, A., Vehreschild, M. J. G. T., Cornely, O. A., Buchheidt, D., Spiess, B., Koldehoff, M., Buer, J., Meis, J. F., & Rath, P.-M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku566 · Cited by 185
Self-citationFavorable outcome of invasive aspergillosis in patients with acute leukemia.
Burch, P. A., Karp, J. E., Merz, W. G., Kuhlman, J. E., & Fishman, E. K. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.12.1985 · Cited by 185
Chong, G. M., van de Sande, W. W. J., Dingemans, G., Gaajetaan, G. R., Vonk, A. G., Hayette, M., van Tegelen, D. W. E., Simons, G., & Rijnders, B. J. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03216-14 · Cited by 154
Kohno, S., Masaoka, T., Yamaguchi, H., Mori, T., Urabe, A., Ito, A., Niki, Y., & IKEMOTO, H. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410020406 · Cited by 154
Viscoli, C., Herbrecht, R., Akan, H., Baila, L., Sonet, A., Gallamini, A., Giagounidis, A., Marchetti, O., Martino, R., Meert, L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp355 · Cited by 154
Self-citationHerbrecht, R., Maertens, J., Baila, L., Aoun, M., Heinz, W., Martino, R., Schwartz, S., Ullmann, A. J., Meert, L., Paesmans, M., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.334 · Cited by 149
Self-citationCentral Nervous System Aspergillosis
Kourkoumpetis, T. K., Desalermos, A. P., Muhammed, M., & Mylonakis, E. E. (2012) · Medicine · doi:10.1097/md.0b013e318274cd77 · Cited by 149
Agarwal, R., Gella, V., Aggarwal, A. N., Garg, M. K., Gupta, D., & Chakrabarti, A. (2013) · Mycoses · doi:10.1111/myc.12075 · Cited by 147
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Ohba, H., Miwa, S., Shirai, M., Kanai, M., Eifuku, T., Suda, T., Hayakawa, H., & Chida, K. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.01.014 · Cited by 140
Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania
Chowdhary, A., Sharma, C., van den Boom, M., Yntema, J. B., Hagen, F., Verweij, P. E., & Meis, J. F. G. M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku259 · Cited by 137
Self-citationFarid, S., Mohamed, S., Devbhandari, M. P., Kneale, M., Richardson, M. D., Soon, S. Y., Jones, M. T., Krysiak, P., Shah, R. D., Denning, D. W., et al. (2013) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-8-180 · Cited by 136
Self-citationLee, J. W., Amantea, M., Francis, P. A., Navarro, E. E., Bacher, J. D., Pizzo, P. A., & Walsh, T. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.713 · Cited by 134
Kohno, S., Izumikawa, K., Ogawa, K., Kurashima, A., Okimoto, N., Amitani, R., Kakeya, H., Niki, Y., & Miyazaki, Y. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.08.005 · Cited by 132
Self-citationAzole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India
Chowdhary, A., Sharma, C., Kathuria, S., Hagen, F., & Meis, J. F. G. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt397 · Cited by 132
Self-citationArendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.01.001 · Cited by 129
Self-citationCNS pharmacokinetics of antifungal agents
Kethireddy, S., & Andes, D. R. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.4.573 · Cited by 128
Self-citationChowdhary, A., Sharma, C., Kathuria, S., Hagen, F., & Meis, J. F. G. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00428 · Cited by 121
Self-citationBadali, H., Vaezi, A., Haghani, I., Yazdanparast, S. A., Hedayati, M. T., Mousavi, B., Ansari, S., Hagen, F., Meis, J. F. G. M., & Chowdhary, A. (2013) · Mycoses · doi:10.1111/myc.12089 · Cited by 114
Self-citationWhite, P. L., Posso, R. B., & Barnes, R. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00667-15 · Cited by 113
Perkhofer, S., Lass‐Flörl, C., Hell, M., Russ, G., Krause, R., Hönigl, M., Geltner, C., Auberger, J., GASTL, G. A., Mitterbauer, M., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.010 · Cited by 106
van Ingen, J., van der Lee, H. A., Rijs, T. A. J., Zoll, J., Leenstra, T., Melchers, W. J. G., & Verweij, P. E. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku364 · Cited by 106
Self-citationEnvironmental Isolates of Azole-Resistant Aspergillus fumigatus in Germany
Bader, O., Tünnermann, J., Dudakova, A., Tangwattanachuleeporn, M., Weig, M., & Groß, U. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00100-15 · Cited by 103
Pharmacological Studies with 5-Fluorocytosine
Block, E. R., & Bennett, J. E. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.1.6.476 · Cited by 101
Astvad, K. M. T., Jensen, R. H., Hassan, T. M., Mathiasen, E. G., Thomsen, G. M., Pedersen, U. G., CHRISTENSEN, M. B., Hilberg, O., & Arendrup, M. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02855-14 · Cited by 100
Self-citationEspinel‐Ingroff, A., Chowdhary, A., González, G. M., Lass‐Flörl, C., Martín‐Mazuelos, E., Meis, J. F. G. M., Peláez, T., Pfaller, M. A., & Turnidge, J. D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00636-13 · Cited by 99
Self-citationMulti‐triazole‐resistant Aspergillus fumigatus infections in Australia
Kidd, S. E., Goeman, E., Meis, J. F. G. M., Slavin, M. A., & Verweij, P. E. (2015) · Mycoses · doi:10.1111/myc.12324 · Cited by 97
Self-citationInvasive Central Nervous System Aspergillosis
Coleman, J. M., Hogg, G. G., Rosenfeld, J. V., & Waters, K. D. (1995) · Neurosurgery · doi:10.1227/00006123-199504000-00032 · Cited by 94
Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
Cornely, O. A., Vehreschild, J. J., Vehreschild, M. J. G. T., Würthwein, G., Arenz, D., Schwartz, S., Heussel, C. P., Silling, G., Mahne, M., Franklin, J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05134-11 · Cited by 93
Self-citationTherapy of Murine Aspergillosis with Amphotericin B in Combination with Rifampin or 5-Fluorocytosine
Arroyo, J. C., Medoff, G., & Kobayashi, G. S. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.1.21 · Cited by 93
Invasive Central Nervous System Aspergillosis
Coleman, J. M., Hogg, G. G., Rosenfeld, J. V., & Waters, K. (1995) · Neurosurgery · doi:10.1097/00006123-199504000-00032 · Cited by 92
Vermeulen, E., Maertens, J. A., Schoemans, H. M., & Lagrou, K. (2012) · Eurosurveillance · doi:10.2807/ese.17.48.20326-en · Cited by 91
Self-citationHerbrecht, R., Patterson, T. F., Slavin, M. A., Marchetti, O., Maertens, J. A., Johnson, E. M., Schlamm, H. T., Donnelly, J. P., & Pappas, P. G. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu911 · Cited by 90
Self-citationLepak, A. J., Marchillo, K., VanHecker, J., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01355-13 · Cited by 88
Self-citationFraczek, M. G., Kirwan, M., Moore, C. B., Morris, J., Denning, D. W., & Richardson, M. D. (2013) · Mycoses · doi:10.1111/myc.12103 · Cited by 86
Self-citationAzole‐Resistant Central Nervous System Aspergillosis
van der Linden, J. W. M., Jansen, R. R., Bresters, D., Visser, C. E., Geerlings, S. E., Kuijper, E. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Clinical Infectious Diseases · doi:10.1086/597465 · Cited by 85
Self-citationAl-shair, K., Atherton, G. T., Harris, C. M., Ratcliffe, L., Newton, P. J., & Denning, D. W. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit411 · Cited by 83
Self-citationAhmad, S., Khan, Z., Hagen, F., & Meis, J. F. G. M. (2014) · Environmental Research · doi:10.1016/j.envres.2014.05.009 · Cited by 75
Self-citationLavergne, R., Morio, F., Favennec, L., Dominique, S., Meis, J. F. G. M., Gargala, G., Verweij, P. E., & Pape, P. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00127-15 · Cited by 74
Self-citationLepak, A. J., Marchillo, K., VanHecker, J., & Andes, D. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01279-12 · Cited by 74
Self-citationPharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model
Seyedmousavi, S., Brüggemann, R. J. M., Meis, J. F. G. M., Melchers, W. J. G., Verweij, P. E., & Mouton, J. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04907-14 · Cited by 72
Self-citationGregson, L., Goodwin, J., Johnson, A., McEntee, L., Moore, C. B., Richardson, M. D., Hope, W. W., & Howard, S. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01141-13 · Cited by 72
KOHNO, S., Izumikawa, K., Yoshida, M., Takesue, Y., Oka, S., Kamei, K., Miyazaki, Y., Yoshinari, T., Kartsonis, N. A., & Niki, Y. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1754-z · Cited by 71
Self-citationSeyedmousavi, S., Brüggemann, R. J. M., Melchers, W. J. G., Rijs, A. J. M. M., Verweij, P. E., & Mouton, J. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks402 · Cited by 70
Self-citationHoward, S. J., Lass‐Flörl, C., Cuenca‐Estrella, M., Gómez‐López, A., & Arendrup, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01111-13 · Cited by 67
Self-citationÖzmerdiven, G. E., Aksoy, S. A., Ener, B., Ağca, H., Cılo, B. D., Tunca, B., & Akalın, H. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.04.012 · Cited by 65
Azole-Resistant Aspergillus fumigatus , Iran
Seyedmousavi, S., Hashemi, S. J., Zibafar, E., Zoll, J., Hedayati, M. T., Mouton, J. W., Melchers, W. J. G., & Verweij, P. E. (2013) · Emerging infectious diseases · doi:10.3201/eid1905.130075 · Cited by 64
Self-citationChishimba, L., Langridge, P., Powell, G., Niven, R. M., & Denning, D. W. (2014) · Journal of Asthma · doi:10.3109/02770903.2014.958853 · Cited by 60
Self-citationRapid Diagnosis of Azole-Resistant Aspergillosis by Direct PCR Using Tissue Specimens
van der Linden, J. W. M., Snelders, E., Arends, J. P., Daenen, S. M. G. J., Melchers, W. J. G., & Verweij, P. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02221-09 · Cited by 60
Self-citationPoor efficacy of amphotericin B‐based therapy in CNS aspergillosis
Schwartz, S., Ruhnke, M., Ribaud, P., Reed, E. C., Troke, P. F., & Thiel, E. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01345.x · Cited by 59
Howard, S. J., Pasqualotto, A. C., Anderson, M. J., Leatherbarrow, H., Albarrag, A., Harrison, E., Gregson, L., Bowyer, P., & Denning, D. W. (2013) · Mycoses · doi:10.1111/myc.12047 · Cited by 54
Self-citationZhao, Y., Stensvold, C. R., Perlin, D. S., & Arendrup, M. C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt071 · Cited by 52
Self-citationPrognostic Factors in 194 Patients with Chronic Necrotizing Pulmonary Aspergillosis
Nakamoto, K., Takayanagi, N., Kanauchi, T., Ishiguro, T., Yanagisawa, T., & Sugita, Y. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.9142 · Cited by 50
Escribano, P., Recio, S., Peláez, T., González-Rivera, M., Bouza, E., & Guinea, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00301-11 · Cited by 48
Seyedmousavi, S., Melchers, W. J. G., Mouton, J. W., & Verweij, P. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02226-12 · Cited by 46
Self-citationReinwald, M., Spieß, B., Heinz, W., Heußel, C. P., Bertz, H., Cornely, O. A., Hahn, J., Lehrnbecher, T., Kiehl, M. G., Laws, H. J., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02387-13 · Cited by 38
Self-citationJeans, A. R., Howard, S. J., Al-Nakeeb, Z., Goodwin, J., Gregson, L., Warn, P. A., & Hope, W. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01111-12 · Cited by 36
Clinical efficacy of micafungin for chronic pulmonary aspergillosis
Izumikawa, K., Ohtsu, Y., Kawabata, M., Takaya, H., Miyamoto, A., Sakamoto, S., Kishi, K., Tsuboi, E., Homma, S. A., & Yoshimura, K. (2007) · Medical Mycology · doi:10.1080/13693780701278386 · Cited by 33
Self-citationCyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
Keir, G. J., Garfield, B. E., Hansell, D. M., Loebinger, M. R., Wilson, R., Renzoni, E. A., Wells, A. U., & Maher, T. M. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203988 · Cited by 33
Global burden of chronic pulmonary aspergillosis as a sequel to tuberculosis.
Denning, D. W., Pleuvry, A., & Cole, D. C. (2011) · Research Explorer (The University of Manchester) · Cited by 31
Self-citationKohno, S., Izumikawa, K., Kakeya, H., Miyazaki, Y., Ogawa, K., Amitani, R., Niki, Y., & Kurashima, A. (2011) · Medical Mycology · doi:10.3109/13693786.2011.561369 · Cited by 27
Self-citationVerweij, P. E., Dorsthorst, D. T. A. T., Janssen, W. H. P., Meis, J. F. G. M., & Mouton, J. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00491-08 · Cited by 24
Self-citation
Cited by
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Verweij, P. E., Chowdhary, A., Melchers, W. J. G., & Meis, J. F. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ885 · Cited by 561
Self-citationVerweij, P. E., Rijnders, B. J. A., Brüggemann, R. J. M., Azoulay, E., Bassetti, M., Blot, S., Calandra, T., Clancy, C. J., Cornely, O. A., Chiller, T., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06091-6 · Cited by 459
Self-citationLestrade, P. P., Bentvelsen, R. G., Schauwvlieghe, A. F. A. D., Schalekamp, S., van der Velden, W. J. F. M., Kuiper, E. J., van Paassen, J., van der Hoven, B., van der Lee, H. A., Melchers, W. J. G., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy859 · Cited by 310
Self-citationClinical implications of globally emerging azole resistance in Aspergillus fumigatus
Meis, J. F., Chowdhary, A., Rhodes, J. L., Fisher, M. C., & Verweij, P. E. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0460 · Cited by 308
Self-citation
Metadata
- Authors
- Verweij, P. E., Ananda-Rajah, M., Andes, D., Arendrup, M. C., Brüggemann, R. J., Chowdhary, A., Cornely, O. A., Denning, D. W., Groll, A. H., Izumikawa, K., Kullberg, B. J., Lagrou, K., Maertens, J., Meis, J. F., Newton, P., Page, I., Seyedmousavi, S., Sheppard, D. C., Viscoli, C., Warris, A., & Donnelly, J. P.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 21-22
- Pages
- 30-40
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2114168745
- Cited by
- 330
- References
- 100
- FWCI
- 31.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.